{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:50:44Z","timestamp":1790887844959,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.drup.2025.101324","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T02:21:40Z","timestamp":1762568500000},"page":"101324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Y10 phosphorylation of LDHA promotes the release of extracellular vesicle-derived circSEPT9 to enhance the chemoresistance of triple negative breast cancer cells via modulation of the miR-515\u20135p\/KIAA1429 axis"],"prefix":"10.1016","volume":"84","author":[{"given":"Yueping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6996-8373","authenticated-orcid":false,"given":"Xuedong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2025.101324_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","article-title":"Pathogenesis of Triple-Negative Breast Cancer","volume":"17","author":"Derakhshan","year":"2022","journal-title":"Annu Rev. Pathol."},{"issue":"2","key":"10.1016\/j.drup.2025.101324_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer - expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101324_bib3","article-title":"Ononin Inhibits Tumor Bone Metastasis and Osteoclastogenesis By Targeting Mitogen-Activated Protein Kinase Pathway in Breast Cancer","volume":"7","author":"Ganesan","year":"2024","journal-title":"Res. (Wash. D. C. )"},{"key":"10.1016\/j.drup.2025.101324_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217734","article-title":"Isoliquiritigenin reduces brain metastasis by circNAV3-ST6GALNAC5-EGFR axis in triple-negative breast cancer","volume":"624","author":"Xie","year":"2025","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.drup.2025.101324_bib5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2217\/epi-2019-0093","article-title":"CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression","volume":"11","author":"Kong","year":"2019","journal-title":"Epigenomics"},{"key":"10.1016\/j.drup.2025.101324_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216508","article-title":"A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer","volume":"581","author":"Wu","year":"2024","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.drup.2025.101324_bib7","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s11010-024-05093-y","article-title":"CircXPO6 promotes breast cancer progression through competitively inhibiting the ubiquitination degradation of c-Myc","volume":"480","author":"Xu","year":"2025","journal-title":"Mol. Cell Biochem"},{"issue":"1","key":"10.1016\/j.drup.2025.101324_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12943-020-01183-9","article-title":"The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer","volume":"19","author":"Zheng","year":"2020","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.drup.2025.101324_bib9","doi-asserted-by":"crossref","first-page":"10624","DOI":"10.1080\/21655979.2021.2000731","article-title":"Knockdown of circular RNA septin 9 inhibits the malignant progression of breast cancer by reducing the expression of solute carrier family 1 member 5 in a microRNA-149-5p-dependent manner","volume":"12","author":"Wang","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.drup.2025.101324_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2023.105055","article-title":"SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9\/GCH1 axis","volume":"292","author":"Song","year":"2024","journal-title":"J. Proteom."},{"issue":"7481","key":"10.1016\/j.drup.2025.101324_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.drup.2025.101324_bib12","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1080\/15476286.2016.1203504","article-title":"mRNA modifications: Dynamic regulators of gene expression?","volume":"13","author":"Hoernes","year":"2016","journal-title":"RNA Biol."},{"issue":"4","key":"10.1016\/j.drup.2025.101324_bib13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","article-title":"Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing","volume":"61","author":"Xiao","year":"2016","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.drup.2025.101324_bib14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12943-022-01620-x","article-title":"Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance","volume":"21","author":"Lin","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101324_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101063","article-title":"Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer","volume":"73","author":"Ou","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2025.101324_bib16","article-title":"POP1 Facilitates Proliferation in Triple-Negative Breast Cancer via m6A-Dependent Degradation of CDKN1A mRNA","volume":"7","author":"Zhang","year":"2024","journal-title":"Res. (Wash. D. C. )"},{"issue":"1","key":"10.1016\/j.drup.2025.101324_bib17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.celrep.2014.05.048","article-title":"Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5\u2032 sites","volume":"8","author":"Schwartz","year":"2014","journal-title":"Cell Rep."},{"issue":"7632","key":"10.1016\/j.drup.2025.101324_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nature20577","article-title":"m(6)A potentiates Sxl alternative pre-mRNA splicing for robust Drosophila sex determination","volume":"540","author":"Haussmann","year":"2016","journal-title":"Nature"},{"issue":"33","key":"10.1016\/j.drup.2025.101324_bib19","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1038\/s41388-019-0861-z","article-title":"KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner","volume":"38","author":"Qian","year":"2019","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.drup.2025.101324_bib20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.15252\/embr.201540970","article-title":"miR-515-5p controls cancer cell migration through MARK4 regulation","volume":"17","author":"Pardo","year":"2016","journal-title":"EMBO Rep."},{"issue":"3","key":"10.1016\/j.drup.2025.101324_bib21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10549-018-4925-5","article-title":"Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells","volume":"172","author":"Ozawa","year":"2018","journal-title":"Breast Cancer Res Treat."},{"issue":"4","key":"10.1016\/j.drup.2025.101324_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043704","article-title":"Therapeutic Implications of the Drug Resistance Conferred by Extracellular Vesicles Derived from Triple-Negative Breast Cancer Cells","volume":"24","author":"Yi","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.drup.2025.101324_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.breast.2016.08.014","article-title":"High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer","volume":"30","author":"Huang","year":"2016","journal-title":"Breast"},{"issue":"27","key":"10.1016\/j.drup.2025.101324_bib24","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1038\/onc.2017.6","article-title":"Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis","volume":"36","author":"Jin","year":"2017","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.drup.2025.101324_bib25","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.scib.2021.01.001","article-title":"Oncogenic lncRNA LINC00973 promotes Warburg effect by enhancing LDHA enzyme activity","volume":"66","author":"Wang","year":"2021","journal-title":"Sci. Bull. (Beijing)"},{"issue":"1","key":"10.1016\/j.drup.2025.101324_bib26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13058-023-01683-8","article-title":"Loss of SPRY2 contributes to cancer-associated fibroblasts activation and promotes breast cancer development","volume":"25","author":"Dai","year":"2023","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.drup.2025.101324_bib27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13046-021-01942-6","article-title":"Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma","volume":"40","author":"Ding","year":"2021","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.drup.2025.101324_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14041","article-title":"Pyruvate kinase type M2 promotes tumour cell exosome release via phosphorylating synaptosome-associated protein 23","volume":"8","author":"Wei","year":"2017","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.drup.2025.101324_bib29","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.1002\/jcp.29608","article-title":"RNA m(6) A methylation regulates uveal melanoma cell proliferation, migration, and invasion by targeting c-Met","volume":"235","author":"Luo","year":"2020","journal-title":"J. Cell Physiol."},{"issue":"1","key":"10.1016\/j.drup.2025.101324_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12943-018-0880-3","article-title":"Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression","volume":"17","author":"Zheng","year":"2018","journal-title":"Mol. Cancer"},{"issue":"20","key":"10.1016\/j.drup.2025.101324_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14205025","article-title":"m(6)A Methyltransferase KIAA1429 Regulates the Cisplatin Sensitivity of Gastric Cancer Cells via Stabilizing FOXM1 mRNA","volume":"14","author":"Zhu","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.drup.2025.101324_bib32","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1002\/cam4.5432","article-title":"KIAA1429 mediates epithelial mesenchymal transition in sorafenib-resistant hepatocellular carcinoma through m6A methylation modification","volume":"12","author":"Kuang","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.drup.2025.101324_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100908","article-title":"KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK\/ MAPK pathway in an m(6)A-dependent manner","volume":"66","author":"Lin","year":"2023","journal-title":"Drug Resist Updat"},{"issue":"2","key":"10.1016\/j.drup.2025.101324_bib34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/art.1780310205","article-title":"Tenderness in 75 anatomic sites. Distinguishing fibromyalgia patients from controls","volume":"31","author":"Simms","year":"1988","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.drup.2025.101324_bib35","first-page":"1887","article-title":"Circular RNA hsa_circ_0008039 promotes proliferation, migration and invasion of breast cancer cells through upregulating CBX4 via sponging miR-515-5p","volume":"24","author":"Huang","year":"2020","journal-title":"Eur. Rev. Med Pharm. Sci."},{"issue":"1","key":"10.1016\/j.drup.2025.101324_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.drup.2025.101324_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13045-022-01345-w","article-title":"CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR","volume":"15","author":"Wang","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.drup.2025.101324_bib38","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/ddr.22069","article-title":"Circular RNAs in the chemoresistance of triple-negative breast cancer: A systematic review","volume":"84","author":"Wang","year":"2023","journal-title":"Drug Dev. Res"},{"issue":"4","key":"10.1016\/j.drup.2025.101324_bib39","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.cell.2018.03.041","article-title":"Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing","volume":"173","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101324_bib40","first-page":"37","article-title":"Competing endogenous RNAs (ceRNAs) and drug resistance to cancer therapy","volume":"7","author":"To","year":"2024","journal-title":"Cancer Drug Resist"},{"issue":"12","key":"10.1016\/j.drup.2025.101324_bib41","article-title":"Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities","volume":"5","author":"Li","year":"2024","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.drup.2025.101324_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101079","article-title":"TRIM29 facilitates gemcitabine resistance via MEK\/ERK pathway and is modulated by circRPS29\/miR-770-5p axis in PDAC","volume":"74","author":"Huang","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2025.101324_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101126","article-title":"crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer","volume":"77","author":"Zou","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2025.101324_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101097","article-title":"CircPDIA3\/miR-449a\/XBP1 feedback loop curbs pyroptosis by inhibiting palmitoylation of the GSDME-C domain to induce chemoresistance of colorectal cancer","volume":"76","author":"Lin","year":"2024","journal-title":"Drug Resist Updat"},{"issue":"8","key":"10.1016\/j.drup.2025.101324_bib45","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1007\/s00432-022-04426-y","article-title":"6)-methyladenosine (m(6)A) writer KIAA1429 accelerates gastric cancer oxaliplatin chemoresistance by targeting FOXM1","volume":"149","author":"Tang","year":"2023","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"9","key":"10.1016\/j.drup.2025.101324_bib46","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2217\/epi-2017-0055","article-title":"Screening circular RNA related to chemotherapeutic resistance in breast cancer","volume":"9","author":"Gao","year":"2017","journal-title":"Epigenomics"},{"issue":"3","key":"10.1016\/j.drup.2025.101324_bib47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7150\/ijbs.24360","article-title":"Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1","volume":"14","author":"Kun-Peng","year":"2018","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.drup.2025.101324_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.966083","article-title":"The role of CircRNA\/miRNA\/mRNA axis in breast cancer drug resistance","volume":"12","author":"Ghazimoradi","year":"2022","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.drup.2025.101324_bib49","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s13046-019-1421-7","article-title":"LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p\/MARK4\/Hippo signaling pathway","volume":"38","author":"Qiao","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.drup.2025.101324_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110059","article-title":"A novel circular RNA (hsa_circRNA_102336), a plausible biomarker, promotes the tumorigenesis by sponging miR-515-5p in human bladder cancer","volume":"126","author":"Gong","year":"2020","journal-title":"Biomed. Pharm."},{"issue":"2","key":"10.1016\/j.drup.2025.101324_bib51","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.1080\/21655979.2021.2005221","article-title":"Regulation of transforming growth factor-beta1 by circANKS1B\/miR-515-5p affects the metastatic potential and cisplatin resistance in oral squamous cell carcinoma","volume":"12","author":"Yan","year":"2021","journal-title":"Bioengineered"},{"issue":"1","key":"10.1016\/j.drup.2025.101324_bib52","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1038\/s41467-018-05096-6","article-title":"Engineering circular RNA for potent and stable translation in eukaryotic cells","volume":"9","author":"Wesselhoeft","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.drup.2025.101324_bib53","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/0008-5472.CAN-21-2988","article-title":"EIF4A3-Induced circARHGAP29 Promotes Aerobic Glycolysis in Docetaxel-Resistant Prostate Cancer through IGF2BP2\/c-Myc\/LDHA Signaling","volume":"82","author":"Jiang","year":"2022","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.drup.2025.101324_bib54","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12943-023-01759-1","article-title":"Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma","volume":"22","author":"Hu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.drup.2025.101324_bib55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41419-020-2230-9","article-title":"circRNA-002178 act as a ceRNA to promote PDL1\/PD1 expression in lung adenocarcinoma","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.drup.2025.101324_bib56","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.7150\/thno.102014","article-title":"Plasma extracellular vesicles from recurrent GBMs carrying LDHA to activate glioblastoma stemness by enhancing glycolysis","volume":"15","author":"Zhang","year":"2025","journal-title":"Theranostics"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S136876462500127X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S136876462500127X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:29:45Z","timestamp":1773318585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S136876462500127X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":56,"alternative-id":["S136876462500127X"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2025.101324","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Y10 phosphorylation of LDHA promotes the release of extracellular vesicle-derived circSEPT9 to enhance the chemoresistance of triple negative breast cancer cells via modulation of the miR-515\u20135p\/KIAA1429 axis","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2025.101324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101324"}}